Cortical Ablation Induces a Spreading Calcium-Dependent, Secondary Pathogenesis Which Can Be Reduced by Inhibiting Calpain
- 28 February 1999
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 155 (2) , 315-326
- https://doi.org/10.1006/exnr.1998.7001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Sustained Delivery of Proteins for Novel Therapeutic ProductsScience, 1998
- Temporal ordering of pathogenic events following transient global ischemiaBrain Research, 1998
- The Calpain Hypothesis of Neurodegeneration: Evidence for a Common Cytotoxic PathwayThe Neuroscientist, 1997
- Time-Related Neuronal Changes following Middle Cerebral Artery Occlusion: Implications for Therapeutic Intervention and the Role of CalpainJournal of Cerebral Blood Flow & Metabolism, 1995
- Calpain as a novel target for treating acute neurodegenerative disordersNeurological Research, 1995
- Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomasThe Lancet, 1995
- Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration.Stroke, 1994
- Postischemic Administration of AK275, a Calpain Inhibitor, Provides Substantial Protection against Focal Ischemic Brain DamageJournal of Cerebral Blood Flow & Metabolism, 1994
- Brain TumorsNew England Journal of Medicine, 1991
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988